センター概要

センター概要

論文・発表支援実績

論文支援

Okada K, Hirono S, Kawai M, Miyazawa M, Shimizu A, Kitahata Y, Ueno M, Hayami S, Shimokawa T, Yamaue H: Prospective validation of patient fatigue questionnaire (FACIT-F) for fatigue assessment in nab-paclitaxel plus gemcitabine therapy, Mol Clin Oncol., 8(1), 121-126, 2018

学内研究支援(第2外科)[統計]

Nagahama T, Yao K, Uedo N, Doyama H, Ueo T, Uchita K, Ishikawa H, Kanesaka T, Takeda Y, Wada K, Imamura K, Arima H, Shimokawa T.: Delineation of the extent of early gastric cancer by magnifying narrow-band imaging and chromoendoscopy: a multicenter randomized controlled trial, Endoscopy, 50(6), 566-576

外部研究支援[統計]

Shimizu A, Kawai M, Hirono S, Okada KI, Miyazawa M, Kitahata Y, Ueno M, Hayami S, Miyamoto A, Kimoto Y, Shimokawa T, Yamaue H.:Postoperative Visceral Tissue Edema Assessed by Computed Tomography Is a Predictor for Severe Complications After Pancreaticoduodenectomy. J. Gastrointest. Surg., 22(1), 77-87, 2018

学内研究支援(第2外科)[統計]

Kodama Y, Kondo T, Matsumura N, Shimokawa T, Kohjimoto Y, Tanabe K, Hara I.: Molecular diagnosis of lymph node metastasis in patients with upper urinary tract cancer who underwent lymphadenectomy. Int. J. Urol., 24(11), 799-806, 2017

学内研究支援(泌尿器科)[統計]

Kaneoke Y, Donishi T, Iwahara A, Shimokawa T.:Severity of Premenstrual Symptoms Predicted by Second to Fourth Digit Ratio., Front. Med., doi: 10.1111/iju.13429

学内研究支援(第1生理)[統計]

Yokoe M, Mano T, Maruo T, Hosomi K, Shimokawa T, Kishima H, Oshino S, Morris S, Kageyama Y, Goto Y, Shimizu T, Mochizuki H, Yoshimine T, Saitoh Y: The optimal stimulation site for high-frequency repetitive transcranial magnetic stimulation in Parkinson’s disease: A double-blind crossover pilot study. J. Clin. Neurosci., 47,72-78,2018

外部研究支援[統計]

Hirono S., Kawai M. Okada K., Miyazawa M., Shimizu A., Kitahara Y., Ueno M., Shimokawa T., Nakao A., Yamaue H.: Mesenteric approach during pancreaticoduodenectomy for pancreatic ducal adenocarcinoma, Annals of Gastroenterological Surgery, 1(3), 2017

学内研究支援(第2外科)[統計]

Inaba Y., Kanaawa N., Yoshimasu T., Shimokawa T., Nosaka M., Kondo T., Furukawa F.: Severer lupus erythematosus-like skin lesions in MRL/lpr mice with homozygous Kitwsh/wsh mutation, Modern Rheumatology, 1(2), 75-81, 2017

学内研究支援(皮膚科)[統計]

Okada K., Shimokawa T., Hirono S., Kawai M., Sho M., Satoi S., Matsumoto I., Eguchi H., Murakami Y., Yamada S., Doi M., Yamaue H.: Effect of Neoadjuvant Nab-Paclitaxel plus Gemcitabine Therapy on Overall Survival in Patients with Borderline Resectable Pancreatic Cancer: A Prospective Multicenter, Phase II trial (NAC-GA trial), Oncology, 93, 343-346, 2017

学内研究支援(第2外科)[統計, DM]

Kurokawa Y., Yang H.K., Cho H., Ryu M.H., Masuzawa T., Park S.R., Matsumoto S., Lee H.J., Honda H., Kwon O.K. Ishikawa T., Lee K.H., Nabeshima K., Kong S.H., Shimokawa T., Yook J.H., Doki Y., Im S.A., Hirota S., Hahn S., Nishida T., Kang Y.K.: Phase II study of neoadjuvant imatinib in large gastrointestinal stromal tumours of the stomach, British Journal of Cancer., doi: 10.1038/bjc.2017.144, 2017

外部研究支援[統計])

Kanemitsu T., Yao K., Nagahama T., Imamura K., Fujiwara S., Ueki T., Chuman K., Tanabe H., Atsuko O., Iwashita A., Shimokawa T., Uchita K., Kanesaka T.: Extending magnifying NBI diagnosis of intestinal metaplasia in the stomach: the white opaque substance marker, Endoscopy., 49(6), 529-535, 2017

外部研究支援[統計]

Futamura M., Nagao Y., Ishihara K., Takeuchi M., Nakada T., Kawaguchi Y., Asano M., Kumazawa I., Shiroko T., Morimitsu K., Mori R., Nawa M., Shimokawa T., Yoshida K.: Preoperative neoadjuvant chemotherapy using nanoparticle albumin-bound paclitaxel followed by epirubicin and cyclophosphamide for operable breast cancer: a multicenter phase II trial., Breast Cancer., 24(4), 615-623, 2017

外部研究支援[統計]

Shimizu T., Hosomi K., Maruo T., Goto Y., Yokoe M., Kageyama Y., Shimokawa T., Yoshimine T., Saitoh Y.: Efficacy of deep rTMS for neuropathic pain in the lower limb: a randomized, double-blinded, crossover, H-coil, figure-8 coil and sham controlled trial, Journal of Neurosurgery, doi: 10.3171/2016.9.JNS16815, 2017

外部研究支援[統計]

Imamura H, Nishikawa K, Kishi K, Inoue K, Matsuyama J, Akamaru Y, Kimura Y, Tamura S, Kawabata R, Kawada J, Fujiwara Y, Kawase T, Fukui J, Takagi M, Takeno A, Shimokawa T.:Effects of an oral elemental nutritional supplement on post-gastrectomy body weight loss in gastric cancer patients: A randomized controlled clinical trial, Ann. Surg. Oncol., 2928-2935, 2016

外部研究支援[統計]

Hosomi K, Morris S, Sakamoto T, Taguchi J, Maruo T, Kageyama Y, Kinoshita Y, Goto Y, Shimokawa T, Koyama T, Saitoh Y.:Daily repetitive transcranial magnetic stimulation for poststroke upper limb paresis in the subacute period, J. Stroke Cerebrovasc Dis., 25(7), 1655-1664, 2016

外部研究支援[統計]

Uchita K, Yao K, Uedo N, Shimokawa T, Iwasaki T, Kojima K, Kawada A, Nakayama M, Okazaki M, Iwamura S.:Highest power magnification with narrow-band imaging is useful for improving diagnostic performance for endoscopic delineation of early gastric cancers., BMC Gastroenterol., doi: 10.1186/s12876-015-0385-0., 2015

外部研究支援[統計]

Ohtsu K, Yao K, Matsunaga K, Nagahama T, Kanemitsu T, Matsushima Y, Yasaka M, Ono Y, Fujiwara S, Hisabe T, Takaki Y, Hirai F, Matsui T, Hanada T, Imamura K, Tanabe H, Iwashita A, Shimokawa T.: Lipid is absorbed in the stomach by epithelial neoplasms (adenomas and early cancers): a novel functional endoscopy technique, Endosc. Int. Open, doi:10.1055/s-0034-1392095, 2015

外部研究支援[統計]

Khoo HM, Kishima H*, Tani N, Oshino S, Maruo T, Hosomi K, Yanagisawa T, Kazui H, Watanabe Y, Shimokawa T, Aso T, Kawaguchi A, Yamashita F, Saitoh Y and Yoshimine T:Default mode network connectivity in patients with idiopathic normal pressure hydrocephalus. Journal of Neurosurgery 124:350-358, 2016

外部研究支援[統計]

Tanaka Y, Takahashi T, Osada S, Shimokawa T and Yoshida K:Elemental diet plus glutamine for the prevention of mucositis in esophageal cancer patients receiving chemotherapy:a feasibility study. Support Care Cancer 24:933-941, 2016

外部研究支援[統計]

Kato M, Uedo N, Nagahama T, Yao K, Doyama H, Tsuji S, Gotoda T, Kawamura T, Ebi M, Yamamoto K, Akasaka T, Takatori H, Handa O, Akamatsu T, Nishikawa J, Hikichi T, Yamashina T, Imoto A, Kitamura Y, Mikami T, Koike T, Ohara S, Kitamura S, Yamaguchi T, Kinjo T, Inoue T, Suzuki S, Kaneko A, Hirasawa K, Tanaka K, Kotachi T, Miwa K, Toya Y, Kayaba S, Ikehata A, Minami S, Mizukami K, Oya H, Ara N, Fukumoto Y, Komura T, Yoshio T, Morizono R, Yamazaki K, Shimodate Y, Yamanouchi K, Kawata N, Kumagai M, Sato Y, Umeki K, Kawai D, Tanuma T, Kishino M, Konishi J, Sumiyoshi T, Oka S, Kono M, Sakamoto T, Horikawa Y, Ohyauchi M, Hashiguchi K, Waseda Y, Kasai T, Aoyagi H, Oyamada H, Shoji M, Kiyotoki S, Asonuma S, Orikasa S, Akaishi C, Nagami Y, Nakata S, Iida F, Nomura T, Tominaga K, Oka K, Morita Y, Suzuki H, Ozeki K, Kuribayashi S, Akazawa Y, Sasaki S, Mikami T, Miki G, Sano T, Satoh H, Nakamura M, Iwai W, Tawa H, Wada M, Yoshimura D, Hisanaga Y, Shimokawa T, Ishikawa H. Self-study of the non-extension sign in an e-learning program improves diagnostic accuracy of invasion depth of early gastric cancer, Endosc Int Open. 2019, 7(7):E871-E882. doi: 10.1055/a-0902-4467.

外部研究支援[統計]

Ishimaru N, Kinami S, Shimokawa T, Kanzawa Y.: Kikyo-to vs. Placebo on Sore Throat Associated with Acute Upper Respiratory Tract Infection: A Randomized Controlled Trial, Intem. Med., in press

外部研究支援[統計・データマネジメント]

Itonaga M, Murata SI, Hatamaru K, Tamura T, Nuta J, Kawaji Y, Maekita T, Iguchi M, Kato J, Kojima F, Yamaue H, Kawai M, Okada KI, Hirono S, Shimokawa T, Tanioka K, Kitano M.: Diagnostic efficacy of smear plus liquid-based cytology for EUS-FNA of solid pancreatic lesions: A propensity-matched study, Medicine, 98(19), e15575, 2019.

学内研究支援(第2内科)[統計]

Tanaka Y, Yamada A, Hirata S, Tanaka H, Sakuratani T, Matsuhashi N, Yamaguchi K, Shimokawa T, Yoshida K.: Efficacy and Safety of Enoxaparin for Prophylaxis of Postoperative Venous Thromboembolism After Esophagectomy: A Single-center Prospective Randomized Controlled Phase II Study, Anticancer Res., 39(5), 2615-2625, 2019.

外部研究支援[統計]

Yamashina T, Uedo N, Akasaka T, Iwatsubo T, Nakatani Y, Akamatsu T, Kawamura T, Takeuchi Y, Fujii S, Kusaka T, Shimokawa T.:Comparison of underwater vs conventional endoscopic mucosal resection of intermediate-size colorectal polyps, Gastroenteology, 157(2), 451-461, 2019.

外部研究支援[統計]

Komatsu H, Yagasaki K., Komatsu Y, Yamauchi H, Yamauchi Y, Shimokawa T, Doorenbos A.Z: Falls and functional impairments in breast cancer patients with chemotherapy-induced peripheral neuropathy, Asia Pac J Oncol Nurs., 6(3), 253-260, 2019.

外部研究支援[統計]

Kaminaka C, Mikita N, Inaba Y, Kunimoto K, Okuhira H, Jinnin M, Kao B, Tanino R, Tanioka K, Shimokawa T, Yamamoto Y.: Clinical and histological evaluation of a single high energy microwave treatment for primary axillary hyperhidrosis in Asians: A prospective, randomized, controlled, split-area comparative trial., Lasers Surg Med., doi: 10.1002/lsm.23073, 2019.

学内研究支援(皮膚科)[統計]

Ojima T, Nakamura M, Nakamori M, Katsuda M, Hayata K, Kitadani J, Maruoka S, Shimokawa T, Yamaue H.: Triplet chemotherapy with docetaxel, cisplatin and S-1 for unresectable advanced squamous cell carcinoma of the esophagus: phase I/II trial results, Oncotarget, 10(8), 847-855, 2019.

学内研究支援(第2外科)[統計]

Endo S, Kurokawa Y, Gamoh M, Kimura Y, Matsuyama J, Taniguchi H, Takeno A, Kawabata R, Kawada J, Masuzawa T, Yamamoto K, Kobayashi K, Sakai D, Shimokawa T, Satoh T.: Trastuzumab With S-1 Plus Cisplatin in HER2-positive Advanced Gastric Cancer Without Measurable Lesions: OGSG 1202, Anticancer Res., 39(2), 1059-1065, 2019.

外部研究支援[統計])

Tsuji T, Ojima T, Nakamori M, Nakamura M, Katsuda M, Hayata K, Kitadani J, Maruoka S, Shimokawa T, Yamaue H.:Triangulating stapling vs functional end-to-end stapling for cervical esophagogastric anastomosis after esophagectomy for thoracic esophageal cancer: study protocol for a randomized controlled trial, Trials, 20(1):83. doi: 10.1186/s13063-019-3201-2, 2019.

学内研究支援(第2外科)[統計]

Hirono S., Kawai M., Okada K., Fujii T., Sho M., Satio S., Amano R., Eguchi H., Mataki Y., Nakamura M., Matsumoto I., Baba H., Tani M. Kawabata Y., Nakagawa Y., Yamada S., Murakami Y., Shimokawa T., Yamaue H.: MAPLE-PD trial; Mesenteric approach vs. conventional approach for pancreatic cancer during pancreaticoduodenectomy: Study protocol for a multicenter randomized controlled trial of 354 patients with pancreatic ductal adenocarcinoma, Trials, 2018, 19(1), doi: 10.1186/s13063-018-3002-z, 2018.

学内研究支援(第2外科)[統計]

Yamashita Y., Shimokawa T., Napoleon B., Fusaroli P., Gincul R., Kubo M., Kitano M.: Value of contrast-enhanced harmonic EUS with enhancement pattern for diagnosis of pancreatic cancer: a meta-analysis, Dig. Endosc., doi: 10.1111/den.13290, 2018.

学内研究支援(第2内科)[統計]

Kitahata Y, Hirono S, Kawai M, Okada KI, Miyazawa M, Shimizu A, Kobayashi R, Ueno M, Hayami S, Shimokawa T, Kouda K, Tajima F, Yamaue H.: Intensive perioperative rehabilitation improves surgical outcomes after pancreaticoduodenectomy, Langenbecks Arch Surg, 403(6), 711-718, 2018.

学内研究支援(第2外科)[統計]

Akamatsu H., Koh Y., Ozawa Y., Fujimoto D., Hata A., Katakami N., Shimokawa T., Yamamoto N.: Osimertinib with ramucirumab in EGFR mutated, T790M-positive patients who had progressed EGFR-TKIs: phase Ib study, Clinical Lung Cancer, doi: 10.1016/j.cllc.2018.08.001, 2018,

学内研究支援(第3内科)[統計]

Ojima T, Nakamura M, Nakamori M, Hayata K, Katsuda M, Kitadani J, Maruoka S, Shimokawa T, Yamaue H.: Robotic versus laparoscopic gastrectomy with lymph node dissection for gastric cancer: study protocol for a randomized controlled trial, Trials, 19(1), 409, doi: 10.1186/s13063-018-2810-5, 2018.

学内研究支援(第2外科)[統計]

Hara I, Yamashita S, Nishizawa S, Kikkawa K, Shimokawa T, Kohjimoto Y: A multicenter randomized Phase III trial of enzalutamide versus abiraterone as a first-line endocrine therapy for castration-resistant prostate cancer, JMIR Research protocols, 7(7): e11191. doi: 10.2196/11191.

学内研究支援(泌尿器科)[統計]

Okada KI, Kawai M, Hirono S, Miyazawa M, Kitahata Y, Ueno M, Hayami S, Shimokawa T, Yamaue H.: Ischemic gastropathy after distal pancreatectomy with en bloc celiac axis resection for pancreatic body cancer, Langenbecks Arch Surg., 403(5), 561-571, 2018.

学内研究支援(第2外科)[統計]

Hamada K, Uedo N, Tonai Y, Arao M, Suzuki S, Iwatsubo T, Kato M, Shichijo S, Yamasaki Y, Matsuura N, Nakahira H, Kanesaka T, Yamamoto S, Akasaka T, Hanaoka N, Takeuchi Y, Higashino K, Ishihara R, Okada H, Iishi H, Fukui K, Shimokawa T.: Efficacy of vonoprazan in prevention of bleeding from endoscopic submucosal dissection-induced gastric ulcers: a prospective randomized phase II study, J.Gastroenteol., 54(2), 122-130, 2019.

外部研究支援[統計]

Yamada S, Fujii T, Kawai M, Shimokawa T, Nakamura M, Murakami Y, Satoi S, Eguchi H, Nagakawa Y, Kodera Y, Yamaue H: Splenic vein resection together with the pancreatic parenchyma versus separated resection after isolation of the parenchyma during distal pancreatectomy: A multicentre, prospective, randomized phase III trial (COSMOS-DP trial), Trials, 19(1), 369, doi: 10.1186/s13063-018-2756-7, 2018.

学内研究支援(第2外科)[統計・データマネジメント]

Kawakami H, Takeno A, Endo S, Makari Y, Kawada J, Taniguchi H, Tamura S, Sugimoto N, Kimura Y, Tamura T, Fujitani K, Sakai D, Shimokawa T, Kurokawa Y, Satoh T: Randomized, open-label phase II study comparing capecitabine-cisplatin every 3 weeks with S-1-cisplatin every 5 weeks in chemotherapy-naïve patients with HER2-negative advanced gastric cancer: OGSG1105, HERBIS-4A trial, The Oncologist, 23(12), 1411-e147, 2018.

外部研究支援[統計]

Ojima T, Nakamura M, Nakamori M, Katsuda M, Hayata K, Maruoka S, Shimokawa T, Yamaue H: Phase I/II Trial of Chemotherapy with Docetaxel, Cisplatin, and S-1 for Unresectable Advanced Squamous Cell Carcinoma of the Esophagus, Oncology, 95(2), 116-120, 2018.

学内研究支援(第2外科)[統計]

Nakashima T, Miyamoto K, Shimokawa T, Kato S, Hayakawa M: The Association Between Sequential Organ Failure Assessment Scores and Mortality in Patients With Sepsis During the First Week: The JSEPTIC DIC Study, J. Intensive Care Med., doi: 10.1177/0885066618775959, 2018.

外部研究支援[統計]

Shimizu T, Hosomi K, Maruo T, Goto Y, Shimokawa T, Haruhiko K, Saitoh Y.: Repetitive transcranial magnetic stimulation accuracy as a spinal cord stimulation outcome predictor in patients with neuropathic pain, J. Clin. Neurosci., 53, 100-105, 2018.

外部研究支援[統計]

Kubo T, Shinke T, Okamura T, Hibi K, Nakazawa G, Mirino Y, Shite J, Ino Y, Kitabata H, Shimokawa T, Akasaka T: Comparison between Optical COherence tomography guidance and Angiography guidance in percutaneous coronary intervention (COCOA): Study protocol for a randomized controlled trial, J. Cardiol, 72(2), 170-175, 2018.

学内研究支援(循環器内科)[統計]

国際会議発表支援

Takeo A, Makari Y, Endo S, Matsuyama J, Kawabata R, Sugimoto N, Taniguchi H, Nagai K, Tamura S, Nishijima J, Ueda S, Kimura Y,Tamura T, Kobayashi K, Kawakami H, Fujitani K, Sakai D, Shimokawa T, Kurokawa Y Satoh T: Randomized, open-label, phase II study comparing five-weekly S-1 plus cisplatin (SP) with tri-weekly capecitabine plus cisplatin (XP) in chemotherapy-naïve patients with HER2 negative advanced gastric cancer (AGC): OGSG 1105 HERBIS-4A trial, 2018 Gastrical Cancers Symposum, American Society of Clinical Oncology, San Francisco, USA, 2018

外部研究支援[統計]

Kawada J, Imamura H, Matsuyama J, Fukui J, Nishikawa K, Kawase T, Shimokawa T, Kurokawa Y, Satoh T, Furukawa H: A phase II study to examine the effectiveness of nutritional support with elemental diet for stage II/III gastric cancer patients receiving adjuvant chemotherapy with S-1 (OGSG 1108), 2017 Gastrical Cancers Symposum, American Society of Clinical Oncology, San Francisco, USA, 2017

外部研究支援[統計]

Matsuyama J, Kurokawa Y, Nishikawa K, Kimura Y, Takeo A, Kawada J, Kawabata R, Makari Y, Tamura S, Doki Y, Sakai D, Shimokawa T, Satoh T: Randomized phase II study to compare docetaxel plus S-1 with cisplatin plus S-1 in advanced gastric cancer without measurable lesions (HERBIS-3), 2017 Gastrical Cancers Symposum, American Society of Clinical Oncology, San Francisco, USA, 2017.

外部研究支援[統計]

Matsuyama J, Kurokawa Y, Nishikawa K, Kimura Y, Takeo A, Kawada J, Kawabata R, Makari Y, Tamura S, Doki Y, Sakai D, Shimokawa T, Satoh T: Randomized phase II study to compare docetaxel plus S-1 with cisplatin plus S-1 in advanced gastric cancer without measurable lesions (HERBIS-3), 2017 Gastrical Cancers Symposum, American Society of Clinical Oncology, San Francisco, USA, 2017.

外部研究支援[統計]

Sugimoto N, Sakai D, Kawada J, Kawabata R, Nishikawa K, Kawase T, Oka Y, Shimizu T, Nishijima J, Hasegawa H, Endo S, Isozaki Y, Kimura Y, Matsuyama J, Kurokawa Y, Shimokawa T, Fujitani K, Satoh T.: A phase II trial of trastuzumab combined with irinotecan in patients with advanced HER2-positive chemo-refractory gastric cancer: OGSG1203 (HERBIS-5), 2016 American Society of Clinical Oncology Annual Meeting, Cicago, USA, 2016

外部研究支援[統計]

Nishikawa K, Sakai D, Kawada J, Kawabata R, Kawase T, Oka Y, Sugimoto B, Shimizu T, Nishijima J, Hasegawa H, Endo S, Isozaki Y, Kimura Y, Matsuyama J, Kurokawa Y, Shimokawa T, Fujitani K, Satoh T:A phase II trial of trastuzumab combined with irinotecan in patients with advanced HER2-positive chemo-refractory gastric cancer:OGSG1203 (HERBIS-5), 2016 Gastrical Cancers Symposum, American Society of Clinical Oncology, San Francisco, USA, 2016

外部研究支援[統計]

Yang HK, Kurokawa Y, Ryu HM, Cho H, Park SR, Masuzawa T, Lee HJ, Matsumoto S, Kwon OK, Honda H, Lee KH, Yamamoto K, Kong SH, Ishikawa T, Yook JH, Nabeshima K, Hahn S, Shimokawa T, Kang YK and Nishida T:A multinational phase II clinical trial of neoadjuvant imatinib for large gastrointestinal stromal tumor of the stomach, 2016 Gastrical Cancers Symposum, American Society of Clinical Oncology, San Francisco, USA, 2016

外部研究支援[統計]

Kawabata R, Sakai D, Kawada J, Nishikawa K, Kawase T, Oka Y, Sugimoto N, Shimizu T, Nishijima J, Hasegawa H, Endo S, Isozaki Y, Kimura Y, Matsuyama J, Kurokawa Y, Shimokawa T, Fujitani and Sato T:A phase II trial of trastuzumab combined with irinotecan in patients with advanced HER2-positive chemo-refractory gastric cancer:Osaka Gastrointestinal Cancer Chemotherapy Study Group OGSG1203 (HERBIS-5), ESMO Asia Congress, Singapore, 2015

外部研究支援[統計]

国内会議発表支援

川端良平・今村博司・川瀬朋乃・松山仁・岡田一幸・西川和宏・柳原一広・下川敏雄・黒川幸典・坂井大介・佐藤太郎:高齢者胃癌に対するS-1+Docetaxel併用療法の第2相試験,第89回 日本胃癌学会総会,2017

外部研究支援[統計]

西川和宏・今村博司・川端良平・松山仁・川瀬朋乃・岡田一幸・下川敏雄・坂井大介・黒川幸典・佐藤太郎・古河洋:高齢者進行胃癌に対するS-1/DTX療法のPhase II試験(OGSG0902)の生存成績,第117回 日本外科学会定期学術集会,2017

外部研究支援[統計]

福井淳一・今村博司・松山仁・西川和宏・川田純司・川瀬朋乃・下川敏雄・黒川幸典・佐藤太郎・古川洋:S-1による胃癌術後補助化学療法患者に対する成分栄養剤(エレンタール)の有用性に関する第II相臨床試験(OGSG1108) ,第117回 日本外科学会定期学術集会,2017

外部研究支援[統計]

松山仁・藤谷和正・木村豊・今村博司・藤田淳也・川端良平・坂井大介・黒川幸典・下川敏雄・佐藤太郎:病期IIIA/IIIB胃癌に対する術後補助化療としてのDTX+S1療法6ヵ月間継続投与のFeasibilityの検討(OGSG1002) ,第72回 日本消化器外科学会総会,2017

外部研究支援[統計]

西川和宏・今村博・松山仁・福井淳一・川田純司・川瀬朋乃・黒川幸典・坂井大介・下川敏雄・佐藤太郎:胃癌術後S-1補助化学療法患者に対するエレンタールの有用性に関する第II相臨床試験(OGSG1108) ,第72回 日本消化器外科学会総会,2017

外部研究支援[統計]

長晴彦・黒川幸典・益澤徹・松本壮平・本多博・山本和義・石川卓・鍋島一仁・下川敏雄・廣田誠一・西田俊朗:「それぞれの癌」難治性癌に対する治療戦略 その他の腫瘍 大型胃GISTに対するイマチニブ術前補助療法の日韓共同第II相試験,第55回 日本癌治療学会学術集会,2017

外部研究支援[統計]

廣野誠子・川井学・岡田健一・宮澤基樹・清水敦史・北畑裕司・小林良平・速水晋也・中村公紀・横山省三・松田健司・上野昌樹・下川敏雄・山上裕機:膵癌に対する膵頭十二指腸切除術におけるmesenteric approachのoncological benefit,第55回 日本癌治療学会学術集会,2017

学内研究支援(第2外科)[統計]

小西慎介・山下真平・下川敏雄・柑本康夫・原勲:前立腺癌骨転移の治療効果判定におけるBone Uptake Value(BUV)法の有用性,第55回 日本癌治療学会学術集会,2017

学内研究支援(泌尿器科)[統計]

岡義雄・坂井大介・川田純司・西川和宏・川端良平・川瀬朋乃・杉本直俊・清水健・長谷川裕子・遠藤俊治・木村豊・松山仁・黒川幸典・下川敏雄・佐藤太郎:IRI+Tmab併用療法の進行・再発HER2陽性胃癌既治療例に対する多施設第II相試験,第88回 日本胃癌学会, 2016

外部研究支援[統計]

藤谷和正・田村茂行・木村豊・今村博司・飯島正平・松山仁・辻毅・藤田淳也・上田修吾・小林研二・井上健太郎・黒川幸典・下川敏雄・佐藤太郎・辻仲利政・古河洋:胃癌の周術期化学療法 上部消化管 胃癌における術後補助化学療法の開発 最適な補助化学療法とは第115回 日本外科学会定期学術集会, 2016

外部研究支援[統計]

清水健・坂井大介・川田純司・西川和宏・川瀬朋乃・岡義雄・川端良平・西嶌準一・遠藤俊治・木村豊・松山仁・野口明則・黒川幸典・下川敏雄・藤谷和正・佐藤太郎:イリノテカン+トラスツズマブ併用療法の進行・再発HER2陽性胃癌既治療例に対する多施設第II相試験OGSG1203(HERBIS-5) 前治療の解析第116回 日本外科学会定期学術集会, 2016

外部研究支援[統計]

遠藤俊治・坂井大介・川田純司・川端良平・岡義雄・西川和宏・藤谷和正・黒川幸典・下川敏雄・佐藤太郎:Irinotecan+Trastuzumabの進行再発HER2陽性胃癌既治療例に対する多施設第II相試験 Dose Intensityの解析,第71回 日本消化器外科学会総会, 2016

外部研究支援[統計]

今村博司・西川和宏・岸健太郎・井上健太郎・松山仁・赤丸祐介・木村豊・田村茂・下川敏雄・広田将司・高田晃宏:外科系診療における早期緩和医療 胃癌根治手術後の体重減少に対する栄養サポートの重要性,第39回 日本外科系連合学会, 2015

外部研究支援[統計]

林邦雄・三井秀紀・塚口眞智子・石川淳・井上信正・浦瀬文明・田窪孝行・野村昌作・前田裕弘・森山康弘・魚嶋伸彦・片桐修一・下川敏雄・亀井克彦・正岡徹:Febrile Neutropenia(FN)治療に対するアムビゾームの有効性と安全性,第63回 日本化学療法学会, 2015

外部研究支援[統計]

今村博司・後藤昌弘・木村豊・上田修吾・松山仁・西川和宏・藤田淳也・杉本直哉・広田将司・高田晃宏・坂井大介・黒川幸典・下川敏雄・辻仲利政・古河洋:2nd line化学療法をどうするか 諸臨床試験の結果をふまえて S-1単独またはS-1/CDDP併用治療抵抗性進行・再発胃癌に対する二次治療のランダム化第II相試験(OGSG0701),第87回 日本胃癌学会, 2015

外部研究支援[統計]

藤田淳也・藤谷和正・田村茂行・木村豊・松山仁・今村博司・飯島正平・上田修吾・下川敏雄・黒川幸典・佐藤太郎・辻仲利政・古河洋・大阪消化管がん化学療法研究会OGSG:Stage III胃癌に対する術後補助化学療法としての6ヵ月間のドセタキセル+S-1投与の検討(OGSG1002),第87回 日本胃癌学会, 2015

外部研究支援[統計]

平尾素宏・藤谷和正・佐藤太郎・木村豊・田村茂行・辻毅・松山仁・飯島正平・今村博司・黒川幸典・下川敏雄・辻仲利政・古河洋・大阪消化器がん化学療法研究会:病期IIIA/B胃癌患者を対象としたドセタキセル+TS1併用術後補助化学療法の第二相試験(OGSG0604)の予後解析,第87回 日本胃癌学会, 2015

外部研究支援[統計]

清水豪士・細見晃一・圓尾知之・後藤雄子・横江勝・影山悠・柳澤琢史・押野悟・貴島晴彦・下川敏雄・吉峰俊樹・齋藤洋一:難治性神経障害性疼痛に対するHコイルによる経頭蓋磁気刺激(rTMS)8の字コイルの除痛効果との比較およびSCSの除痛効果との相関,第43回 臨床神経生理学, 2015

外部研究支援[統計]